Selected research
Industry Research
Molecular Docking and Virtual Screening Software Industry Research Report 2026
Market perspective
The global Molecular Docking and Virtual Screening Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Molecular Docking and Virtual Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Molecular Docking and Virtual Screening Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Molecular Docking and Virtual Screening Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Molecular Docking and Virtual Screening Software include OpenEye Cadence Molecular Sciences, Cambridge Crystallographic Data Centre, Cresset, BioSolveIT, Molsoft, Molecular Discovery, DP Technology, XtalPi and Schrödinger, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Molecular Docking and Virtual Screening Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Molecular Docking and Virtual Screening Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Docking and Virtual Screening Software Market by Company
OpenEye Cadence Molecular Sciences
Cambridge Crystallographic Data Centre
Cresset
BioSolveIT
Molsoft
Molecular Discovery
DP Technology
XtalPi
Schrödinger
Dassault Systèmes
Chemical Computing Group
Molecular Docking and Virtual Screening Software Segment by Type
Structure-Based Docking Software
Ligand-Based Screening Software
Pharmacophore Screening Software
Shape and Electrostatic Similarity Software
AI-Assisted Docking Software
Molecular Docking and Virtual Screening Software Segment by Application
Hit Discovery
Lead Optimization
Drug Repurposing
Fragment-Based Drug Design
Target Validation and Mechanism Study
Teaching and Academic Research
Molecular Docking and Virtual Screening Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Docking and Virtual Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Docking and Virtual Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Docking and Virtual Screening Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Molecular Docking and Virtual Screening Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Structure-Based Docking Software
- Ligand-Based Screening Software
- Pharmacophore Screening Software
- Shape and Electrostatic Similarity Software
- AI-Assisted Docking Software
Applications
- Hit Discovery
- Lead Optimization
- Drug Repurposing
- Fragment-Based Drug Design
- Target Validation and Mechanism Study
- Teaching and Academic Research
Companies covered
- OpenEye Cadence Molecular Sciences
- Cambridge Crystallographic Data Centre
- Cresset
- BioSolveIT
- Molsoft
- Molecular Discovery
- DP Technology
- XtalPi
- Schrödinger
- Dassault Systèmes
- Chemical Computing Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Molecular Docking and Virtual Screening Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Structure-Based Docking Software
- 2.2.3 Ligand-Based Screening Software
- 2.2.4 Pharmacophore Screening Software
- 2.2.5 Shape and Electrostatic Similarity Software
- 2.2.6 AI-Assisted Docking Software
- 2.3 Molecular Docking and Virtual Screening Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hit Discovery
- 2.3.3 Lead Optimization
- 2.3.4 Drug Repurposing
- 2.3.5 Fragment-Based Drug Design
- 2.3.6 Target Validation and Mechanism Study
- 2.3.7 Teaching and Academic Research
- 2.4 Assumptions and Limitations
3 Molecular Docking and Virtual Screening Software Breakdown Data by Type
- 3.1 Global Molecular Docking and Virtual Screening Software Historic Market Size by Type (2021-2026)
- 3.2 Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Type (2027-2032)
4 Molecular Docking and Virtual Screening Software Breakdown Data by Application
- 4.1 Global Molecular Docking and Virtual Screening Software Historic Market Size by Application (2021-2026)
- 4.2 Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Molecular Docking and Virtual Screening Software Market Perspective (2021-2032)
- 5.2 Global Molecular Docking and Virtual Screening Software Growth Trends by Region
- 5.2.1 Global Molecular Docking and Virtual Screening Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Molecular Docking and Virtual Screening Software Historic Market Size by Region (2021-2026)
- 5.2.3 Molecular Docking and Virtual Screening Software Forecasted Market Size by Region (2027-2032)
- 5.3 Molecular Docking and Virtual Screening Software Market Dynamics
- 5.3.1 Molecular Docking and Virtual Screening Software Industry Trends
- 5.3.2 Molecular Docking and Virtual Screening Software Market Drivers
- 5.3.3 Molecular Docking and Virtual Screening Software Market Challenges
- 5.3.4 Molecular Docking and Virtual Screening Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Molecular Docking and Virtual Screening Software Players by Revenue
- 6.1.1 Global Top Molecular Docking and Virtual Screening Software Players by Revenue (2021-2026)
- 6.1.2 Global Molecular Docking and Virtual Screening Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Molecular Docking and Virtual Screening Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Molecular Docking and Virtual Screening Software Head Office and Area Served
- 6.4 Global Molecular Docking and Virtual Screening Software Players, Product Type & Application
- 6.5 Global Molecular Docking and Virtual Screening Software Manufacturers Established Date
- 6.6 Global Molecular Docking and Virtual Screening Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Molecular Docking and Virtual Screening Software Market Size (2021-2032)
- 7.2 North America Molecular Docking and Virtual Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
- 7.4 North America Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Molecular Docking and Virtual Screening Software Market Size (2021-2032)
- 8.2 Europe Molecular Docking and Virtual Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
- 8.4 Europe Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Docking and Virtual Screening Software Market Size (2021-2032)
- 9.2 Asia-Pacific Molecular Docking and Virtual Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Molecular Docking and Virtual Screening Software Market Size (2021-2032)
- 10.2 South America Molecular Docking and Virtual Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
- 10.4 South America Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Docking and Virtual Screening Software Market Size (2021-2032)
- 11.2 Middle East & Africa Molecular Docking and Virtual Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 OpenEye Cadence Molecular Sciences
- 12.1.1 OpenEye Cadence Molecular Sciences Company Information
- 12.1.2 OpenEye Cadence Molecular Sciences Business Overview
- 12.1.3 OpenEye Cadence Molecular Sciences Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.1.4 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio
- 12.1.5 OpenEye Cadence Molecular Sciences Recent Developments
- 12.2 Cambridge Crystallographic Data Centre
- 12.2.1 Cambridge Crystallographic Data Centre Company Information
- 12.2.2 Cambridge Crystallographic Data Centre Business Overview
- 12.2.3 Cambridge Crystallographic Data Centre Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.2.4 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio
- 12.2.5 Cambridge Crystallographic Data Centre Recent Developments
- 12.3 Cresset
- 12.3.1 Cresset Company Information
- 12.3.2 Cresset Business Overview
- 12.3.3 Cresset Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.3.4 Cresset Molecular Docking and Virtual Screening Software Product Portfolio
- 12.3.5 Cresset Recent Developments
- 12.4 BioSolveIT
- 12.4.1 BioSolveIT Company Information
- 12.4.2 BioSolveIT Business Overview
- 12.4.3 BioSolveIT Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.4.4 BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio
- 12.4.5 BioSolveIT Recent Developments
- 12.5 Molsoft
- 12.5.1 Molsoft Company Information
- 12.5.2 Molsoft Business Overview
- 12.5.3 Molsoft Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.5.4 Molsoft Molecular Docking and Virtual Screening Software Product Portfolio
- 12.5.5 Molsoft Recent Developments
- 12.6 Molecular Discovery
- 12.6.1 Molecular Discovery Company Information
- 12.6.2 Molecular Discovery Business Overview
- 12.6.3 Molecular Discovery Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.6.4 Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio
- 12.6.5 Molecular Discovery Recent Developments
- 12.7 DP Technology
- 12.7.1 DP Technology Company Information
- 12.7.2 DP Technology Business Overview
- 12.7.3 DP Technology Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.7.4 DP Technology Molecular Docking and Virtual Screening Software Product Portfolio
- 12.7.5 DP Technology Recent Developments
- 12.8 XtalPi
- 12.8.1 XtalPi Company Information
- 12.8.2 XtalPi Business Overview
- 12.8.3 XtalPi Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.8.4 XtalPi Molecular Docking and Virtual Screening Software Product Portfolio
- 12.8.5 XtalPi Recent Developments
- 12.9 Schrödinger
- 12.9.1 Schrödinger Company Information
- 12.9.2 Schrödinger Business Overview
- 12.9.3 Schrödinger Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.9.4 Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio
- 12.9.5 Schrödinger Recent Developments
- 12.10 Dassault Systèmes
- 12.10.1 Dassault Systèmes Company Information
- 12.10.2 Dassault Systèmes Business Overview
- 12.10.3 Dassault Systèmes Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.10.4 Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio
- 12.10.5 Dassault Systèmes Recent Developments
- 12.11 Chemical Computing Group
- 12.11.1 Chemical Computing Group Company Information
- 12.11.2 Chemical Computing Group Business Overview
- 12.11.3 Chemical Computing Group Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
- 12.11.4 Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio
- 12.11.5 Chemical Computing Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst